Clinical overlap between malaria and pneumonia: can malaria rapid diagnostic test play a role?

Kingsley Nnanna Ukwaja1, Olufemi B Aina, Ademola A Talabi

  • 1Comprehensive Health Centre, Oke-Ilewo, Abeokuta, Ogun State, Nigeria. ukwajakingsley@yahoo.co.uk

Insights

In African children, malaria and pneumonia symptoms often overlap. Rapid diagnostic tests can help avoid unnecessary antimalarial drug prescriptions when diagnosing these overlapping illnesses.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Malaria and pneumonia are leading causes of mortality in children under five in sub-Saharan Africa.
  • Integrated Management of Childhood Illnesses (IMCI) strategy is used due to limited diagnostics, leading to dual classifications and treatments.
  • Symptom overlap between malaria and pneumonia necessitates co-treatment with antibiotics and antimalarials.

Purpose of the Study:

  • To determine the prevalence of malaria-pneumonia symptom overlap in children.
  • To confirm malaria diagnoses in cases with overlapping symptoms using rapid diagnostic tests (RDTs).

Main Methods:

  • A study involving 1,216 children (2 months to 5 years) over three months.
  • Malaria RDTs were administered exclusively to children presenting with overlapping malaria and pneumonia symptoms.

Main Results:

  • 90% of children presented with cough or fever.
  • 23% of all enrolled children met criteria for both malaria and pneumonia.
  • Only 46% of children with overlapping symptoms tested positive for malaria via RDT.

Conclusions:

  • Dual treatment for malaria and pneumonia may lead to over-prescription of antimalarials.
  • Implementing malaria RDTs can prevent unnecessary antimalarial medication use in children with overlapping symptoms.
Abstract

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...